Tenaya Therapeutics CEO to present at Cell & Gene Meeting

By The Science Advisory Board staff writers

October 12, 2021 -- Faraz Ali, CEO of biotechnology firm Tenaya Therapeutics, will present on October 13 at 3:15 p.m. PT as part of a panel discussion at the Cell & Gene Meeting on the Mesa in Carlsbad, CA.

Ali will participate in the session titled, "Personalizing Cardiovascular Therapies to Address the Underlying Causes of Disease." The panel will discuss cell and gene therapies in cardiovascular medicine. Tenaya Therapeutics will also have a company presentation at 4:45 p.m. PT on October 13.

Tenaya Therapeutics develops gene therapies for rare genetic disorders and for more prevalent heart conditions through three product platforms: gene therapy, cellular regeneration, and precision medicine.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.